Garrido, M.P.; Salvatierra, R.; Valenzuela-Valderrama, M.; Vallejos, C.; Bruneau, N.; Hernández, A.; Vega, M.; Selman, A.; Quest, A.F.G.; Romero, C.
Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells. Pharmaceuticals 2020, 13, 315.
https://doi.org/10.3390/ph13100315
AMA Style
Garrido MP, Salvatierra R, Valenzuela-Valderrama M, Vallejos C, Bruneau N, Hernández A, Vega M, Selman A, Quest AFG, Romero C.
Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells. Pharmaceuticals. 2020; 13(10):315.
https://doi.org/10.3390/ph13100315
Chicago/Turabian Style
Garrido, Maritza P., Renato Salvatierra, Manuel Valenzuela-Valderrama, Christopher Vallejos, Nicole Bruneau, Andrea Hernández, Margarita Vega, Alberto Selman, Andrew F. G. Quest, and Carmen Romero.
2020. "Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells" Pharmaceuticals 13, no. 10: 315.
https://doi.org/10.3390/ph13100315
APA Style
Garrido, M. P., Salvatierra, R., Valenzuela-Valderrama, M., Vallejos, C., Bruneau, N., Hernández, A., Vega, M., Selman, A., Quest, A. F. G., & Romero, C.
(2020). Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells. Pharmaceuticals, 13(10), 315.
https://doi.org/10.3390/ph13100315